Catalogo dei prodotti della ricerca

RINZIVILLO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.642
EU - Europa 739
AS - Asia 363
AF - Africa 20
SA - Sud America 9
OC - Oceania 3
Totale 2.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.610
IT - Italia 369
SG - Singapore 200
IE - Irlanda 90
SE - Svezia 89
IN - India 59
FI - Finlandia 53
CN - Cina 45
BE - Belgio 40
ID - Indonesia 40
CA - Canada 27
DE - Germania 21
GB - Regno Unito 20
UA - Ucraina 13
BG - Bulgaria 10
TG - Togo 10
AR - Argentina 6
PK - Pakistan 6
AT - Austria 5
CH - Svizzera 5
HK - Hong Kong 5
NG - Nigeria 5
RO - Romania 5
SI - Slovenia 5
UG - Uganda 5
FR - Francia 4
MX - Messico 4
BR - Brasile 3
PH - Filippine 3
AU - Australia 2
ES - Italia 2
LT - Lituania 2
NL - Olanda 2
RU - Federazione Russa 2
TW - Taiwan 2
IQ - Iraq 1
LI - Liechtenstein 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
TR - Turchia 1
Totale 2.776
Salva come PNG Salva come JPEG
Città #
Fairfield 323
Singapore 151
Chandler 139
Rome 137
Ashburn 109
Dublin 88
Woodbridge 88
Seattle 73
Cambridge 72
Houston 72
Santa Clara 57
Wilmington 50
Princeton 49
Lawrence 45
Millbury 42
Brussels 40
Jakarta 40
New York 40
San Paolo di Civitate 39
San Diego 30
Milan 28
Ann Arbor 25
Helsinki 23
Lappeenranta 21
Ottawa 19
Boardman 15
Beijing 12
Boston 12
Plano 11
Lomé 10
London 10
Shanghai 10
Sofia 10
Andover 8
Des Moines 7
Fara in Sabina 7
Norwalk 7
Dearborn 6
Federal 6
Fucecchio 6
Toronto 6
Bologna 5
Calvanico 5
Falkenstein 5
Grottammare 5
Kampala 5
Lagos 5
Ljubljana 5
Stockholm 5
Dallas 4
Falls Church 4
Guangzhou 4
Phoenix 4
San Mateo 4
Terni 4
Bühl 3
Cebu City 3
Frankfurt am Main 3
Islamabad 3
Livorno 3
Mannheim 3
Multan 3
Naples 3
Palmetto 3
Pontedera 3
Redmond 3
Segrate 3
Tenhult 3
Vienna 3
Vignola 3
Atlanta 2
Birmingham 2
Bremen 2
Casalecchio di Reno 2
Casanova Lonati 2
Catania 2
Civita Castellana 2
El Paso 2
Fremont 2
Hong Kong 2
Hyderabad 2
Lake City 2
Lamezia Terme 2
Macerata 2
Marino 2
Menlo Park 2
Mexico City 2
Nanjing 2
Nocera Inferiore 2
Ozzano dell'Emilia 2
Palermo 2
Paris 2
Parma 2
Prescot 2
Québec 2
Sacramento 2
Taipei 2
Trescore Balneario 2
Veroli 2
Verona 2
Totale 2.112
Salva come PNG Salva come JPEG
Nome #
A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH 111
CT texture analysis of liver metastases in PNETs versus NPNETs. correlation with histopathological findings 97
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 95
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia 90
Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs. a systematic review 89
[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia 83
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 81
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors 79
Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs 74
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 70
Digestive neuroendocrine neoplasms. A 2016 overview 68
Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience 68
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 66
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study 65
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center 65
Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia. A Case Series 65
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs. A Multicenter Study 59
Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia. A Systematic Review 56
Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review 55
Advanced digestive neuroendocrine tumors. metastatic pattern is an independent factor affecting clinical outcome 50
Management of type-I gastric neuroendocrine neoplasms. A 10-years prospective single centre study 49
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 49
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm. Study Protocol for a Prospective Observational Study 47
Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. 46
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia. a multicentre retrospective study 45
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia 45
Diagnostic and therapeutic management of primary orbital neuroendocrine tumors (NETs): systematic literature review and clinical case presentation 44
Prognostic significance of laterality in lung neuroendocrine tumors 44
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 43
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 43
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 43
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms. The NOVARA Score, a Multicentre Retrospective Study 43
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors 42
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms. Data from a large international cohort study 41
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function 39
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix. A Multicentric Retrospective Study 39
Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response 37
Linee guida NEOPLASIE NEUROENDOCRINE 36
Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia 36
The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs 36
Bone Metastases in Neuroendocrine Tumors. Molecular Pathogenesis and Implications in Clinical Practice 36
What gastroenterologists should know about carcinoid syndrome 32
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 32
Everolimus in pancreatic neuroendocrine carcinomas G3 31
Management of functional pancreatic neuroendocrine neoplasms 30
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia 30
The role of combined Ga-DOTANOC and 18FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors 30
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: data from a retrospective multi-centric study 30
Gastro-entero-pancreatic neuroendocrine neoplasia. The rules for non-operative management 29
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: a comparison between pancreatic and gastrointestinal localizations 28
Risk of preoperative understaging of duodenal neuroendocrine neoplasms. a plea for caution in the treatment strategy 28
Sporadic non-functioning pancreatic neuroendocrine tumours. multicentre analysis 28
Reply to Dr. Hall and coworkers 27
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome 26
Necrolytic migratory erythema impact on prognosis and diagnosis of glucagonoma: a case report 24
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? 23
Metastatic Type 1 low-grade gastric neuroendocrine tumor treated with peptide receptor radionuclide therapy in a young adult: a case report 22
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastro entero pancreatic neuroendocrine tumors. alternatives to RECIST 22
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 22
Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management 21
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors. A Systematic Review and Meta-Analysis 21
Targeting neuroendocrine tumors with octreotide and lanreotide. Key points for clinical practice from NET specialists 20
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors. Answers and Unsolved Problems 17
Clinical outcome of patients with gastric, duodenal, or rectal neuroendocrine tumors after incomplete endoscopic resection 16
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size. a retrospective, Europe-wide, pooled cohort study 16
Controversies in the treatment of digestive neuroendocrine tumors 15
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells 14
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review 14
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 14
Risk and protective factors for small intestine neuroendocrine tumors: a prospective case-control study 13
Therapy for Locoregional Disease. Stomach/Duodenum, Colon/Rectum 10
Sarcopenia in patients with advanced gastrointestinal well-differentiated neuroendocrine tumors 10
Treatment of Intestinal NETs (Including Appendix) 9
Sequencing treatments in patients with advanced well-differentiated pancreatic neuroendocrine tumor (pNET): results from a large multicenter italian cohort 8
New Prognostic Frontiers for Lung Neuroendocrine Tumors 8
Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review 7
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs 7
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm. interim analysis of prospective ASPEN trial 7
Totale 3.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 0 25 44 40 43 27 15 19
2020/2021175 20 14 20 12 5 4 0 9 23 27 22 19
2021/2022857 2 14 19 14 52 19 17 49 173 100 312 86
2022/2023690 98 141 44 46 70 43 11 38 125 17 38 19
2023/2024483 30 50 17 43 32 65 39 34 13 49 68 43
2024/2025495 54 63 123 114 71 70 0 0 0 0 0 0
Totale 3.110